Empagliflozin and linagliptin and Imiglucerase Intravenous
Determining the interaction of Empagliflozin and linagliptin and Imiglucerase Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
Generic Name: imiglucerase
Brand name: Cerezyme
Synonyms: Imiglucerase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and linagliptin-Imipenem and cilastatin
- Empagliflozin and linagliptin-Imipenem and Cilastatin Injection
- Empagliflozin and linagliptin-Imipenem and cilastatin Intravenous, Intramuscular
- Empagliflozin and linagliptin-Imipenem, Cilastatin, and Relebactam
- Empagliflozin and linagliptin-Imipramine
- Empagliflozin and linagliptin-Imipramine Capsules
- Imiglucerase Intravenous-Empagliflozin and metformin
- Imiglucerase Intravenous-Empagliflozin and Metformin Extended-Release Tablets
- Imiglucerase Intravenous-Empagliflozin and Metformin Tablets
- Imiglucerase Intravenous-Empliciti
- Imiglucerase Intravenous-Emsam
- Imiglucerase Intravenous-Emsam Transdermal